ES
Insider selling
Eugene Schneider sold $2.1M of Ionis Pharmaceuticals Inc (IONS) stock
Eugene Schneider, EVP, Chf Clinical Develop Ofcr of Ionis Pharmaceuticals Inc (IONS), sold 26,000 shares of IONS stock worth $2.1M, per an SEC Form 4 filed Jun 30, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 26, 2026, 4 days before it was made public.
IONS has moved -45.3% since the trade date, from $81.18 to $44.44 (Sep 18, 2026 close).
- Traded
- Jun 26, 2026
- Disclosed
- Jun 30, 2026
- Filing delay
- 4 days
- Price since
- -45.3%
- Role
- EVP, Chf Clinical Develop Ofcr
- Source
- SEC Form 4
More IONS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.